

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 9.29919451 |
| 2 | regulation of cholesterol esterification (GO:0010872) | 8.72551138 |
| 3 | plasma lipoprotein particle assembly (GO:0034377) | 8.54087277 |
| 4 | very-low-density lipoprotein particle assembly (GO:0034379) | 7.68696966 |
| 5 | protein-lipid complex assembly (GO:0065005) | 7.56989394 |
| 6 | high-density lipoprotein particle remodeling (GO:0034375) | 7.56889011 |
| 7 | cholesterol efflux (GO:0033344) | 7.19862993 |
| 8 | negative regulation of fibrinolysis (GO:0051918) | 7.07810985 |
| 9 | macromolecular complex remodeling (GO:0034367) | 6.79868181 |
| 10 | plasma lipoprotein particle remodeling (GO:0034369) | 6.79868181 |
| 11 | protein-lipid complex remodeling (GO:0034368) | 6.79868181 |
| 12 | reverse cholesterol transport (GO:0043691) | 6.75830992 |
| 13 | positive regulation of antigen processing and presentation (GO:0002579) | 6.65491998 |
| 14 | regulation of T-helper 1 cell differentiation (GO:0045625) | 6.63126552 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.58517777 |
| 16 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 6.53117027 |
| 17 | protein carboxylation (GO:0018214) | 6.52063857 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.52063857 |
| 19 | regulation of fibrinolysis (GO:0051917) | 6.48999386 |
| 20 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 6.45279858 |
| 21 | negative regulation of cholesterol transport (GO:0032375) | 6.22006794 |
| 22 | negative regulation of sterol transport (GO:0032372) | 6.22006794 |
| 23 | low-density lipoprotein particle remodeling (GO:0034374) | 6.12909470 |
| 24 | plasma lipoprotein particle organization (GO:0071827) | 6.07819064 |
| 25 | plasma lipoprotein particle clearance (GO:0034381) | 6.06175568 |
| 26 | negative regulation of lipase activity (GO:0060192) | 6.02702891 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.95671193 |
| 28 | protein-lipid complex subunit organization (GO:0071825) | 5.69781928 |
| 29 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.58339400 |
| 30 | regulation of antigen processing and presentation (GO:0002577) | 5.52719470 |
| 31 | regulation of complement activation (GO:0030449) | 5.30562474 |
| 32 | dendritic cell chemotaxis (GO:0002407) | 5.27147513 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.23475165 |
| 34 | L-phenylalanine catabolic process (GO:0006559) | 5.23475165 |
| 35 | glyoxylate metabolic process (GO:0046487) | 5.22563622 |
| 36 | blood coagulation, intrinsic pathway (GO:0007597) | 5.12952977 |
| 37 | positive regulation of granulocyte chemotaxis (GO:0071624) | 5.11700016 |
| 38 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 4.99971573 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.93504433 |
| 40 | L-phenylalanine metabolic process (GO:0006558) | 4.93504433 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.87737011 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.87737011 |
| 43 | regulation of bile acid biosynthetic process (GO:0070857) | 4.82157523 |
| 44 | cellular anion homeostasis (GO:0030002) | 4.73377781 |
| 45 | imidazole-containing compound metabolic process (GO:0052803) | 4.72497028 |
| 46 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.72134058 |
| 47 | detection of bacterium (GO:0016045) | 4.64776533 |
| 48 | positive regulation of interleukin-1 secretion (GO:0050716) | 4.64372111 |
| 49 | regulation of interleukin-1 beta secretion (GO:0050706) | 4.62774475 |
| 50 | regulation of activation of Janus kinase activity (GO:0010533) | 4.54016492 |
| 51 | regulation of plasminogen activation (GO:0010755) | 4.52607234 |
| 52 | detection of other organism (GO:0098543) | 4.50883638 |
| 53 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.49401535 |
| 54 | cholesterol homeostasis (GO:0042632) | 4.49105392 |
| 55 | sterol transport (GO:0015918) | 4.44804999 |
| 56 | cholesterol transport (GO:0030301) | 4.44804999 |
| 57 | sterol homeostasis (GO:0055092) | 4.42745962 |
| 58 | positive regulation of steroid metabolic process (GO:0045940) | 4.39993253 |
| 59 | positive regulation of neutrophil chemotaxis (GO:0090023) | 4.37148736 |
| 60 | positive regulation of neutrophil migration (GO:1902624) | 4.37148736 |
| 61 | dendritic cell migration (GO:0036336) | 4.36934447 |
| 62 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.36781907 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 4.34119297 |
| 64 | fibrinolysis (GO:0042730) | 4.31659686 |
| 65 | phospholipid homeostasis (GO:0055091) | 4.27696379 |
| 66 | lipoprotein metabolic process (GO:0042157) | 4.24123026 |
| 67 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.23473478 |
| 68 | trivalent inorganic anion homeostasis (GO:0072506) | 4.22363358 |
| 69 | phosphate ion homeostasis (GO:0055062) | 4.22363358 |
| 70 | proline metabolic process (GO:0006560) | 4.15648683 |
| 71 | complement activation, alternative pathway (GO:0006957) | 4.13752296 |
| 72 | muscle atrophy (GO:0014889) | 4.12606667 |
| 73 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.11092405 |
| 74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.11092405 |
| 75 | response to nitric oxide (GO:0071731) | 4.07645576 |
| 76 | striated muscle atrophy (GO:0014891) | 4.07014561 |
| 77 | superoxide anion generation (GO:0042554) | 4.06357407 |
| 78 | regulation of interleukin-1 secretion (GO:0050704) | 4.02379002 |
| 79 | negative regulation of hemostasis (GO:1900047) | 4.00661295 |
| 80 | negative regulation of blood coagulation (GO:0030195) | 4.00661295 |
| 81 | synapsis (GO:0007129) | 3.98003390 |
| 82 | peptide catabolic process (GO:0043171) | 3.96832675 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 3.94609427 |
| 84 | regulation of T-helper 1 type immune response (GO:0002825) | 3.92879512 |
| 85 | single strand break repair (GO:0000012) | 3.89989527 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 3.85200865 |
| 87 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.81074333 |
| 88 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.80100369 |
| 89 | regulation of lipoprotein particle clearance (GO:0010984) | 3.76183115 |
| 90 | diacylglycerol metabolic process (GO:0046339) | 3.75640170 |
| 91 | bile acid metabolic process (GO:0008206) | 3.73684867 |
| 92 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.73076726 |
| 93 | bile acid biosynthetic process (GO:0006699) | 3.72455896 |
| 94 | regulation of granulocyte chemotaxis (GO:0071622) | 3.68208022 |
| 95 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.68097691 |
| 96 | regulation of neutrophil chemotaxis (GO:0090022) | 3.67724895 |
| 97 | regulation of neutrophil migration (GO:1902622) | 3.67724895 |
| 98 | negative regulation of coagulation (GO:0050819) | 3.67285487 |
| 99 | cellular glucuronidation (GO:0052695) | 3.62216872 |
| 100 | uronic acid metabolic process (GO:0006063) | 3.56065861 |
| 101 | glucuronate metabolic process (GO:0019585) | 3.56065861 |
| 102 | lipid homeostasis (GO:0055088) | 3.56010889 |
| 103 | cytokine secretion (GO:0050663) | 3.55872720 |
| 104 | glutamate metabolic process (GO:0006536) | 3.54863494 |
| 105 | negative regulation of wound healing (GO:0061045) | 3.53816510 |
| 106 | intestinal cholesterol absorption (GO:0030299) | 3.52155896 |
| 107 | regulation of apoptotic cell clearance (GO:2000425) | 3.50126189 |
| 108 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.50102253 |
| 109 | regulation of humoral immune response (GO:0002920) | 3.49967838 |
| 110 | skeletal muscle adaptation (GO:0043501) | 3.49946420 |
| 111 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.42377750 |
| 112 | sulfate transport (GO:0008272) | 3.38671589 |
| 113 | epoxygenase P450 pathway (GO:0019373) | 3.37000630 |
| 114 | response to prostaglandin E (GO:0034695) | 3.36952152 |
| 115 | phospholipid efflux (GO:0033700) | 3.36537398 |
| 116 | positive regulation of interleukin-1 production (GO:0032732) | 3.36503990 |
| 117 | regulation of hexokinase activity (GO:1903299) | 3.36481827 |
| 118 | regulation of glucokinase activity (GO:0033131) | 3.36481827 |
| 119 | protein activation cascade (GO:0072376) | 3.36117398 |
| 120 | positive regulation of blood coagulation (GO:0030194) | 3.33990224 |
| 121 | positive regulation of hemostasis (GO:1900048) | 3.33990224 |
| 122 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.30995058 |
| 123 | detection of external biotic stimulus (GO:0098581) | 3.29209737 |
| 124 | nitrogen cycle metabolic process (GO:0071941) | 3.27572030 |
| 125 | energy homeostasis (GO:0097009) | 3.27395633 |
| 126 | detection of biotic stimulus (GO:0009595) | 3.26998260 |
| 127 | regulation of T-helper cell differentiation (GO:0045622) | 3.26751775 |
| 128 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.22558969 |
| 129 | lipoxygenase pathway (GO:0019372) | 3.22259837 |
| 130 | positive regulation of lipid catabolic process (GO:0050996) | 3.20338025 |
| 131 | regulation of cholesterol transport (GO:0032374) | 3.20311921 |
| 132 | regulation of sterol transport (GO:0032371) | 3.20311921 |
| 133 | serine family amino acid catabolic process (GO:0009071) | 3.19802211 |
| 134 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.19388851 |
| 135 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.18468647 |
| 136 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.18055901 |
| 137 | acute-phase response (GO:0006953) | 3.15604799 |
| 138 | L-ascorbic acid metabolic process (GO:0019852) | 3.14677689 |
| 139 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.14245375 |
| 140 | positive regulation of coagulation (GO:0050820) | 3.13980715 |
| 141 | ethanol oxidation (GO:0006069) | 3.12710643 |
| 142 | negative regulation of muscle hypertrophy (GO:0014741) | 3.11727400 |
| 143 | heme transport (GO:0015886) | 3.11529579 |
| 144 | neutral lipid catabolic process (GO:0046461) | 3.11215990 |
| 145 | acylglycerol catabolic process (GO:0046464) | 3.11215990 |
| 146 | positive regulation of prostaglandin secretion (GO:0032308) | 3.09220234 |
| 147 | positive regulation of heat generation (GO:0031652) | 3.07531802 |
| 148 | drug transmembrane transport (GO:0006855) | 3.07360534 |
| 149 | positive regulation of icosanoid secretion (GO:0032305) | 3.07265042 |
| 150 | glycine metabolic process (GO:0006544) | 3.06357382 |
| 151 | positive regulation of cholesterol efflux (GO:0010875) | 3.06150641 |
| 152 | regulation of helicase activity (GO:0051095) | 3.05950074 |
| 153 | positive regulation of interleukin-12 production (GO:0032735) | 3.04746440 |
| 154 | aromatic amino acid family catabolic process (GO:0009074) | 3.04158084 |
| 155 | reactive oxygen species biosynthetic process (GO:1903409) | 3.04132253 |
| 156 | negative regulation of lipid transport (GO:0032369) | 3.02653803 |
| 157 | response to pheromone (GO:0019236) | 3.00647228 |
| 158 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.00452207 |
| 159 | polyketide metabolic process (GO:0030638) | 2.99113733 |
| 160 | doxorubicin metabolic process (GO:0044598) | 2.99113733 |
| 161 | daunorubicin metabolic process (GO:0044597) | 2.99113733 |
| 162 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.98681552 |
| 163 | intestinal absorption (GO:0050892) | 2.98625931 |
| 164 | regulation of acrosome reaction (GO:0060046) | 2.98242900 |
| 165 | NIK/NF-kappaB signaling (GO:0038061) | 2.96659722 |
| 166 | angiotensin maturation (GO:0002003) | 2.95360043 |
| 167 | response to prostaglandin (GO:0034694) | 2.94175107 |
| 168 | leukocyte tethering or rolling (GO:0050901) | 2.94129127 |
| 169 | dendritic cell differentiation (GO:0097028) | 2.93748616 |
| 170 | urea metabolic process (GO:0019627) | 2.92736417 |
| 171 | urea cycle (GO:0000050) | 2.92736417 |
| 172 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.91232095 |
| 173 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.90835520 |
| 174 | lipoprotein transport (GO:0042953) | 2.90566686 |
| 175 | NAD biosynthetic process (GO:0009435) | 2.88707939 |
| 176 | ovulation from ovarian follicle (GO:0001542) | 2.88053846 |
| 177 | cellular response to ATP (GO:0071318) | 2.86139801 |
| 178 | renal absorption (GO:0070293) | 2.80781574 |
| 179 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.74893891 |
| 180 | cellular protein complex localization (GO:0034629) | 2.72217956 |
| 181 | anion homeostasis (GO:0055081) | 2.72205908 |
| 182 | positive regulation of sterol transport (GO:0032373) | 2.70747804 |
| 183 | positive regulation of cholesterol transport (GO:0032376) | 2.70747804 |
| 184 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.70516030 |
| 185 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.70516030 |
| 186 | regulation of fever generation (GO:0031620) | 2.68621891 |
| 187 | positive regulation of leukocyte migration (GO:0002687) | 2.67566423 |
| 188 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.66564951 |
| 189 | nitric oxide biosynthetic process (GO:0006809) | 2.65202971 |
| 190 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.64510197 |
| 191 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.57022470 |
| 192 | DNA strand renaturation (GO:0000733) | 2.56310062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.87759167 |
| 2 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.82024013 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.80144561 |
| 4 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.80602651 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.79857164 |
| 6 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.79112886 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.27239989 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.19320820 |
| 9 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 3.11919930 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.00440180 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.95548232 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.93260330 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.77653174 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.69836750 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.69471585 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.68507754 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.65392455 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.58696735 |
| 19 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.57322479 |
| 20 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.48221842 |
| 21 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.29551177 |
| 22 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.29514612 |
| 23 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.19371839 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.17589949 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.17154578 |
| 26 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.01969160 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 2.01936314 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00272080 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4338997 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.95723940 |
| 31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.94105462 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.89142975 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.85492672 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85031135 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.81589494 |
| 36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.76753980 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75069787 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72143821 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71184941 |
| 40 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.70978269 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.68865334 |
| 42 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.66342919 |
| 43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.65434662 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65191747 |
| 45 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.64389257 |
| 46 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.62443436 |
| 47 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.62130730 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61677600 |
| 49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.61635770 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59462779 |
| 51 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.58368584 |
| 52 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.55690988 |
| 53 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.55322072 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.55303447 |
| 55 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.54936789 |
| 56 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.54865732 |
| 57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.53872594 |
| 58 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.53401106 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52819461 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52218656 |
| 61 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.52204066 |
| 62 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.50625235 |
| 63 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.49482243 |
| 64 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.48877991 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48281436 |
| 66 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.46657831 |
| 67 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.45721788 |
| 68 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.44254622 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43946201 |
| 70 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.42135935 |
| 71 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.40802521 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40522808 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40165536 |
| 74 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.40041866 |
| 75 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.39115356 |
| 76 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.38511632 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.37224026 |
| 78 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.35283557 |
| 79 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.34983444 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33793938 |
| 81 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.33031879 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.32612632 |
| 83 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31353095 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29434769 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28859758 |
| 86 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26170159 |
| 87 | KDM2B_26808549_Chip-Seq_REH_Human | 1.22842927 |
| 88 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21615973 |
| 89 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21497853 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19266607 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18245823 |
| 92 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.16661079 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16621956 |
| 94 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14154335 |
| 95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14060180 |
| 96 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13538602 |
| 97 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12558175 |
| 98 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.11744979 |
| 99 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.10570583 |
| 100 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.10570583 |
| 101 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.10570583 |
| 102 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.10424127 |
| 103 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10412547 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09921932 |
| 105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09583956 |
| 106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08170122 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06379020 |
| 108 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06139175 |
| 109 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05478645 |
| 110 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05353931 |
| 111 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05280958 |
| 112 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04838172 |
| 113 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03868687 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03507230 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02460884 |
| 116 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01980505 |
| 117 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.01731943 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01643037 |
| 119 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00781462 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00521857 |
| 121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00337373 |
| 122 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99469341 |
| 123 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99248675 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97408182 |
| 125 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96830235 |
| 126 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96501310 |
| 127 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96312333 |
| 128 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95899674 |
| 129 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95676772 |
| 130 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.95657513 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95200579 |
| 132 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95013177 |
| 133 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94273194 |
| 134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93116914 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92956266 |
| 136 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.92624986 |
| 137 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92202944 |
| 138 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92169760 |
| 139 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91335188 |
| 140 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90113936 |
| 141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89776594 |
| 142 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89042752 |
| 143 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88920393 |
| 144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88813118 |
| 145 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.88268567 |
| 146 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84585359 |
| 147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84013819 |
| 148 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81880817 |
| 149 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81833417 |
| 150 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80417075 |
| 151 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79799043 |
| 152 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79661127 |
| 153 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.76760455 |
| 154 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.73890538 |
| 155 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.72988800 |
| 156 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.71366737 |
| 157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70931420 |
| 158 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70757494 |
| 159 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70687058 |
| 160 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.70055248 |
| 161 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.68615331 |
| 162 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.66473253 |
| 163 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.65986510 |
| 164 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.65414312 |
| 165 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.65414312 |
| 166 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.65301594 |
| 167 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.65046536 |
| 168 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64533563 |
| 169 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.63030018 |
| 170 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.62255268 |
| 171 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.61325492 |
| 172 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.61021568 |
| 173 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.59663207 |
| 174 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59576362 |
| 175 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.59056840 |
| 176 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.59017369 |
| 177 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58236612 |
| 178 | RXR_22108803_ChIP-Seq_LS180_Human | 0.58007426 |
| 179 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57961080 |
| 180 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.56968555 |
| 181 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.56708530 |
| 182 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.56244842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 7.07958487 |
| 2 | MP0002876_abnormal_thyroid_physiology | 5.12209242 |
| 3 | MP0000685_abnormal_immune_system | 3.93441208 |
| 4 | MP0005647_abnormal_sex_gland | 3.75027704 |
| 5 | MP0001346_abnormal_lacrimal_gland | 3.61652254 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.50529942 |
| 7 | MP0003122_maternal_imprinting | 3.08332593 |
| 8 | MP0008057_abnormal_DNA_replication | 3.07549532 |
| 9 | MP0009697_abnormal_copulation | 3.05865445 |
| 10 | MP0003718_maternal_effect | 3.01069185 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.95795368 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 2.83224719 |
| 13 | MP0006082_CNS_inflammation | 2.75121741 |
| 14 | MP0005360_urolithiasis | 2.60394315 |
| 15 | MP0001873_stomach_inflammation | 2.53983539 |
| 16 | MP0005310_abnormal_salivary_gland | 2.32190931 |
| 17 | MP0002277_abnormal_respiratory_mucosa | 2.28280717 |
| 18 | MP0001348_abnormal_lacrimal_gland | 2.27253968 |
| 19 | MP0002160_abnormal_reproductive_system | 2.18318531 |
| 20 | MP0005408_hypopigmentation | 2.15539842 |
| 21 | MP0003195_calcinosis | 2.02349125 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.84223278 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.84170918 |
| 24 | MP0009785_altered_susceptibility_to | 1.76794704 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 1.69842042 |
| 26 | MP0003123_paternal_imprinting | 1.68463005 |
| 27 | MP0005671_abnormal_response_to | 1.66653038 |
| 28 | MP0005085_abnormal_gallbladder_physiolo | 1.60273000 |
| 29 | MP0005503_abnormal_tendon_morphology | 1.60049353 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.59943632 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.58995621 |
| 32 | MP0009764_decreased_sensitivity_to | 1.58506039 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.56403727 |
| 34 | MP0004510_myositis | 1.54733690 |
| 35 | MP0005377_hearing/vestibular/ear_phenot | 1.52455615 |
| 36 | MP0003878_abnormal_ear_physiology | 1.52455615 |
| 37 | MP0005451_abnormal_body_composition | 1.47995713 |
| 38 | MP0005025_abnormal_response_to | 1.47438701 |
| 39 | MP0003879_abnormal_hair_cell | 1.46933467 |
| 40 | MP0008004_abnormal_stomach_pH | 1.46825445 |
| 41 | MP0005395_other_phenotype | 1.44450468 |
| 42 | MP0000609_abnormal_liver_physiology | 1.41692449 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.35122805 |
| 44 | MP0003724_increased_susceptibility_to | 1.31863887 |
| 45 | MP0001881_abnormal_mammary_gland | 1.26830379 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.26614545 |
| 47 | MP0000566_synostosis | 1.26527601 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.26424195 |
| 49 | MP0005389_reproductive_system_phenotype | 1.25866513 |
| 50 | MP0000604_amyloidosis | 1.24799978 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.24149664 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.23868348 |
| 53 | MP0005365_abnormal_bile_salt | 1.23641550 |
| 54 | MP0003941_abnormal_skin_development | 1.22588469 |
| 55 | MP0005448_abnormal_energy_balance | 1.21236028 |
| 56 | MP0002419_abnormal_innate_immunity | 1.18961909 |
| 57 | MP0001915_intracranial_hemorrhage | 1.18483827 |
| 58 | MP0003252_abnormal_bile_duct | 1.17990095 |
| 59 | MP0002132_abnormal_respiratory_system | 1.17032356 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.15562137 |
| 61 | MP0003121_genomic_imprinting | 1.15198885 |
| 62 | MP0005000_abnormal_immune_tolerance | 1.12536746 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.11667187 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.09500366 |
| 65 | MP0003699_abnormal_female_reproductive | 1.08539119 |
| 66 | MP0001790_abnormal_immune_system | 1.07921216 |
| 67 | MP0005387_immune_system_phenotype | 1.07921216 |
| 68 | MP0010030_abnormal_orbit_morphology | 1.07548962 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.05962195 |
| 70 | MP0006292_abnormal_olfactory_placode | 1.04622737 |
| 71 | MP0001800_abnormal_humoral_immune | 1.04282032 |
| 72 | MP0000538_abnormal_urinary_bladder | 1.03802446 |
| 73 | MP0005409_darkened_coat_color | 1.03154384 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01934596 |
| 75 | MP0002796_impaired_skin_barrier | 1.00716972 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.00714090 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.99967369 |
| 78 | MP0003045_fibrosis | 0.99764268 |
| 79 | MP0004272_abnormal_basement_membrane | 0.99705765 |
| 80 | MP0001845_abnormal_inflammatory_respons | 0.98640965 |
| 81 | MP0010329_abnormal_lipoprotein_level | 0.98593626 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.98117724 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.97735996 |
| 84 | MP0001764_abnormal_homeostasis | 0.95746584 |
| 85 | MP0002723_abnormal_immune_serum | 0.95265910 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.92541407 |
| 87 | MP0005334_abnormal_fat_pad | 0.92023156 |
| 88 | MP0002452_abnormal_antigen_presenting | 0.91223127 |
| 89 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90691870 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.88802167 |
| 91 | MP0002971_abnormal_brown_adipose | 0.87820964 |
| 92 | MP0003959_abnormal_lean_body | 0.87437307 |
| 93 | MP0008469_abnormal_protein_level | 0.86797352 |
| 94 | MP0002405_respiratory_system_inflammati | 0.86661492 |
| 95 | MP0000598_abnormal_liver_morphology | 0.86479515 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.86077553 |
| 97 | MP0003868_abnormal_feces_composition | 0.83712425 |
| 98 | MP0000470_abnormal_stomach_morphology | 0.82717176 |
| 99 | MP0003828_pulmonary_edema | 0.82669070 |
| 100 | MP0002089_abnormal_postnatal_growth/wei | 0.82573020 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.81144451 |
| 102 | MP0001663_abnormal_digestive_system | 0.80910885 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.79505624 |
| 104 | MP0009115_abnormal_fat_cell | 0.79444356 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.78616432 |
| 106 | MP0000383_abnormal_hair_follicle | 0.78014085 |
| 107 | MP0005501_abnormal_skin_physiology | 0.76518856 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.75208241 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.74777655 |
| 110 | MP0001819_abnormal_immune_cell | 0.74273449 |
| 111 | MP0009840_abnormal_foam_cell | 0.74207262 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.74032952 |
| 113 | MP0005499_abnormal_olfactory_system | 0.72876033 |
| 114 | MP0005394_taste/olfaction_phenotype | 0.72876033 |
| 115 | MP0004947_skin_inflammation | 0.72565631 |
| 116 | MP0002938_white_spotting | 0.71511833 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.70733535 |
| 118 | MP0002420_abnormal_adaptive_immunity | 0.69199992 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.68970316 |
| 120 | MP0005332_abnormal_amino_acid | 0.68875268 |
| 121 | MP0005023_abnormal_wound_healing | 0.67804798 |
| 122 | MP0000613_abnormal_salivary_gland | 0.67533184 |
| 123 | MP0008058_abnormal_DNA_repair | 0.67443895 |
| 124 | MP0008789_abnormal_olfactory_epithelium | 0.67145149 |
| 125 | MP0002090_abnormal_vision | 0.66486525 |
| 126 | MP0001324_abnormal_eye_pigmentation | 0.66370323 |
| 127 | MP0005410_abnormal_fertilization | 0.65910359 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.64852948 |
| 129 | MP0001986_abnormal_taste_sensitivity | 0.64721675 |
| 130 | MP0003315_abnormal_perineum_morphology | 0.64172090 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.63835657 |
| 132 | MP0002161_abnormal_fertility/fecundity | 0.62942681 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.61865972 |
| 134 | MP0002118_abnormal_lipid_homeostasis | 0.61269864 |
| 135 | MP0001485_abnormal_pinna_reflex | 0.59919125 |
| 136 | MP0002233_abnormal_nose_morphology | 0.59804448 |
| 137 | MP0001730_embryonic_growth_arrest | 0.59438052 |
| 138 | MP0003806_abnormal_nucleotide_metabolis | 0.59051613 |
| 139 | MP0005670_abnormal_white_adipose | 0.58742149 |
| 140 | MP0005084_abnormal_gallbladder_morpholo | 0.58017727 |
| 141 | MP0003186_abnormal_redox_activity | 0.58011685 |
| 142 | MP0002098_abnormal_vibrissa_morphology | 0.57526733 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.56797172 |
| 144 | MP0001661_extended_life_span | 0.55665652 |
| 145 | MP0001929_abnormal_gametogenesis | 0.54341745 |
| 146 | MP0005551_abnormal_eye_electrophysiolog | 0.54319053 |
| 147 | MP0003329_amyloid_beta_deposits | 0.53670615 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.52159201 |
| 149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48557785 |
| 150 | MP0001756_abnormal_urination | 0.48141419 |
| 151 | MP0001119_abnormal_female_reproductive | 0.47400950 |
| 152 | MP0003011_delayed_dark_adaptation | 0.46127468 |
| 153 | MP0006054_spinal_hemorrhage | 0.46097065 |
| 154 | MP0003953_abnormal_hormone_level | 0.46081124 |
| 155 | MP0003119_abnormal_digestive_system | 0.43820076 |
| 156 | MP0002078_abnormal_glucose_homeostasis | 0.42755493 |
| 157 | MP0000653_abnormal_sex_gland | 0.41644324 |
| 158 | MP0001270_distended_abdomen | 0.39708198 |
| 159 | MP0005257_abnormal_intraocular_pressure | 0.38200596 |
| 160 | MP0001293_anophthalmia | 0.37949723 |
| 161 | MP0002909_abnormal_adrenal_gland | 0.36552086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.91885845 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 7.41182728 |
| 3 | Spontaneous abortion (HP:0005268) | 6.56932664 |
| 4 | Abnormality of the common coagulation pathway (HP:0010990) | 6.24535784 |
| 5 | Joint hemorrhage (HP:0005261) | 5.83371187 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.81854206 |
| 7 | Hypolipoproteinemia (HP:0010981) | 5.48079117 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.42340018 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.33120759 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.27233488 |
| 11 | Increased IgE level (HP:0003212) | 5.22509734 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 5.09721074 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.09721074 |
| 14 | Xanthomatosis (HP:0000991) | 4.58612362 |
| 15 | Complement deficiency (HP:0004431) | 4.58054037 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.42806657 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.21758755 |
| 18 | Keratoconjunctivitis (HP:0001096) | 4.01955791 |
| 19 | Glomerulonephritis (HP:0000099) | 3.84104423 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.68228487 |
| 21 | Hydroxyprolinuria (HP:0003080) | 3.68100464 |
| 22 | Abnormality of proline metabolism (HP:0010907) | 3.68100464 |
| 23 | Prostate neoplasm (HP:0100787) | 3.61599340 |
| 24 | Hypercholesterolemia (HP:0003124) | 3.57616411 |
| 25 | Acanthocytosis (HP:0001927) | 3.39462488 |
| 26 | Hypophosphatemic rickets (HP:0004912) | 3.35407225 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.32492514 |
| 28 | Right ventricular cardiomyopathy (HP:0011663) | 3.31825231 |
| 29 | Broad alveolar ridges (HP:0000187) | 3.30590114 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28541752 |
| 31 | Abnormality of complement system (HP:0005339) | 3.28428378 |
| 32 | Amyloidosis (HP:0011034) | 3.23388787 |
| 33 | Abnormality of carpal bone ossification (HP:0006257) | 3.22576054 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.21948566 |
| 35 | Hyperlipoproteinemia (HP:0010980) | 3.20934801 |
| 36 | Cheilitis (HP:0100825) | 3.17218530 |
| 37 | Recurrent skin infections (HP:0001581) | 3.16441814 |
| 38 | Menorrhagia (HP:0000132) | 3.14956908 |
| 39 | Pustule (HP:0200039) | 3.11818619 |
| 40 | Gingivitis (HP:0000230) | 3.11471943 |
| 41 | Epidermoid cyst (HP:0200040) | 3.04340396 |
| 42 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.04150295 |
| 43 | Upper limb muscle weakness (HP:0003484) | 2.93840301 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.91699123 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.88018284 |
| 46 | Type I diabetes mellitus (HP:0100651) | 2.86845906 |
| 47 | Retinal atrophy (HP:0001105) | 2.83487371 |
| 48 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.78479878 |
| 49 | Palmoplantar hyperkeratosis (HP:0000972) | 2.78129669 |
| 50 | Urticaria (HP:0001025) | 2.77271165 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.76168316 |
| 52 | Optic neuritis (HP:0100653) | 2.76168316 |
| 53 | Chromsome breakage (HP:0040012) | 2.75480723 |
| 54 | Orchitis (HP:0100796) | 2.74389764 |
| 55 | Poikilocytosis (HP:0004447) | 2.73771734 |
| 56 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.72125184 |
| 57 | Conjugated hyperbilirubinemia (HP:0002908) | 2.71610431 |
| 58 | Thrombophlebitis (HP:0004418) | 2.71191316 |
| 59 | Steatorrhea (HP:0002570) | 2.71078393 |
| 60 | Palmar hyperkeratosis (HP:0010765) | 2.70594059 |
| 61 | Abnormal tarsal ossification (HP:0008369) | 2.69801128 |
| 62 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.69620612 |
| 63 | Generalized aminoaciduria (HP:0002909) | 2.66739148 |
| 64 | Congenital malformation of the right heart (HP:0011723) | 2.65528592 |
| 65 | Double outlet right ventricle (HP:0001719) | 2.65528592 |
| 66 | Hyperglycinemia (HP:0002154) | 2.65322310 |
| 67 | Plantar hyperkeratosis (HP:0007556) | 2.59545943 |
| 68 | Supernumerary spleens (HP:0009799) | 2.58727313 |
| 69 | Absent/shortened dynein arms (HP:0200106) | 2.58612206 |
| 70 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.58612206 |
| 71 | Hepatoblastoma (HP:0002884) | 2.58430424 |
| 72 | Prolonged neonatal jaundice (HP:0006579) | 2.57777954 |
| 73 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.55771914 |
| 74 | Tongue fasciculations (HP:0001308) | 2.54283867 |
| 75 | Facial shape deformation (HP:0011334) | 2.52763896 |
| 76 | Potter facies (HP:0002009) | 2.52763896 |
| 77 | Hypoglycemic coma (HP:0001325) | 2.51373319 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.51183227 |
| 79 | Febrile seizures (HP:0002373) | 2.50706665 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.50186826 |
| 81 | Xerostomia (HP:0000217) | 2.48496297 |
| 82 | Recurrent pneumonia (HP:0006532) | 2.48046109 |
| 83 | Vascular calcification (HP:0004934) | 2.46456145 |
| 84 | Cholecystitis (HP:0001082) | 2.46150220 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.46150220 |
| 86 | Ileus (HP:0002595) | 2.45473593 |
| 87 | Rickets (HP:0002748) | 2.44813152 |
| 88 | Abnormal hand bone ossification (HP:0010660) | 2.42164667 |
| 89 | Septo-optic dysplasia (HP:0100842) | 2.42012265 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 2.37360987 |
| 91 | Proximal tubulopathy (HP:0000114) | 2.35154626 |
| 92 | Osteomalacia (HP:0002749) | 2.34130501 |
| 93 | Abnormal delivery (HP:0001787) | 2.30409552 |
| 94 | Hyperglycemia (HP:0003074) | 2.29525625 |
| 95 | Renal cortical cysts (HP:0000803) | 2.28974390 |
| 96 | Abnormal ossification of hand bones (HP:0005921) | 2.27811118 |
| 97 | Tetraparesis (HP:0002273) | 2.27520124 |
| 98 | Gangrene (HP:0100758) | 2.26037090 |
| 99 | Alopecia of scalp (HP:0002293) | 2.25659532 |
| 100 | Aplasia cutis congenita (HP:0001057) | 2.24970919 |
| 101 | Type 2 muscle fiber atrophy (HP:0003554) | 2.24466106 |
| 102 | Chronic diarrhea (HP:0002028) | 2.24212811 |
| 103 | Premature loss of primary teeth (HP:0006323) | 2.22109901 |
| 104 | Flat acetabular roof (HP:0003180) | 2.18947526 |
| 105 | Obstructive lung disease (HP:0006536) | 2.16593087 |
| 106 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16593087 |
| 107 | Confusion (HP:0001289) | 2.16516461 |
| 108 | Keratitis (HP:0000491) | 2.14903201 |
| 109 | Myositis (HP:0100614) | 2.13752265 |
| 110 | Periodontitis (HP:0000704) | 2.12552676 |
| 111 | Hyperammonemia (HP:0001987) | 2.10185353 |
| 112 | Abnormality of the nasal septum (HP:0000419) | 2.09613192 |
| 113 | Cardiovascular calcification (HP:0011915) | 2.09416906 |
| 114 | Abnormality of methionine metabolism (HP:0010901) | 2.08105039 |
| 115 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.06560674 |
| 116 | Muscle fibrillation (HP:0010546) | 2.05972170 |
| 117 | Systemic lupus erythematosus (HP:0002725) | 2.05967072 |
| 118 | Enlarged kidneys (HP:0000105) | 2.05626438 |
| 119 | Lip pit (HP:0100267) | 2.04793473 |
| 120 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.04572956 |
| 121 | Glycosuria (HP:0003076) | 2.03014050 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 2.03014050 |
| 123 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.02631778 |
| 124 | Asplenia (HP:0001746) | 2.00764974 |
| 125 | Joint swelling (HP:0001386) | 2.00112737 |
| 126 | Gingival bleeding (HP:0000225) | 1.99735523 |
| 127 | Nephritis (HP:0000123) | 1.99101362 |
| 128 | Increased IgM level (HP:0003496) | 1.98867939 |
| 129 | Abnormality of the gastric mucosa (HP:0004295) | 1.98613531 |
| 130 | Hypobetalipoproteinemia (HP:0003563) | 1.97907336 |
| 131 | Fair hair (HP:0002286) | 1.97512624 |
| 132 | Abnormality of the intrinsic pathway (HP:0010989) | 1.97179425 |
| 133 | Decreased central vision (HP:0007663) | 1.96088109 |
| 134 | Stomatitis (HP:0010280) | 1.95628194 |
| 135 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.95202345 |
| 136 | Hypoplasia of the fovea (HP:0007750) | 1.95202345 |
| 137 | Autoimmune thrombocytopenia (HP:0001973) | 1.95096341 |
| 138 | Broad palm (HP:0001169) | 1.94703043 |
| 139 | Increased serum pyruvate (HP:0003542) | 1.94538072 |
| 140 | Prenatal maternal abnormality (HP:0002686) | 1.94494159 |
| 141 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93299466 |
| 142 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.92570989 |
| 143 | Abnormality of the renal cortex (HP:0011035) | 1.92095111 |
| 144 | Nausea (HP:0002018) | 1.91927564 |
| 145 | Abnormality of the alveolar ridges (HP:0006477) | 1.91309935 |
| 146 | Malnutrition (HP:0004395) | 1.91172439 |
| 147 | Hepatocellular carcinoma (HP:0001402) | 1.91067661 |
| 148 | Pigmentary retinal degeneration (HP:0001146) | 1.88889296 |
| 149 | Supernumerary nipples (HP:0002558) | 1.88314283 |
| 150 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87536848 |
| 151 | Abnormality of eosinophils (HP:0001879) | 1.87346485 |
| 152 | Unilateral renal agenesis (HP:0000122) | 1.87254796 |
| 153 | Myocardial infarction (HP:0001658) | 1.86803817 |
| 154 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85807315 |
| 155 | Widely patent fontanelles and sutures (HP:0004492) | 1.85249852 |
| 156 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.85206368 |
| 157 | Abnormality of glycine metabolism (HP:0010895) | 1.85206368 |
| 158 | Elevated alkaline phosphatase (HP:0003155) | 1.84674426 |
| 159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84199825 |
| 160 | Fat malabsorption (HP:0002630) | 1.82422135 |
| 161 | Flared iliac wings (HP:0002869) | 1.82025215 |
| 162 | Abnormality of the preputium (HP:0100587) | 1.81987863 |
| 163 | Mitral stenosis (HP:0001718) | 1.81986286 |
| 164 | Papillary thyroid carcinoma (HP:0002895) | 1.81490234 |
| 165 | Thick nail (HP:0001805) | 1.81306368 |
| 166 | Reduced antithrombin III activity (HP:0001976) | 1.80758224 |
| 167 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80695460 |
| 168 | Dehydration (HP:0001944) | 1.79836900 |
| 169 | Clubbing of toes (HP:0100760) | 1.77450581 |
| 170 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77185555 |
| 171 | Respiratory distress (HP:0002098) | 1.76265222 |
| 172 | Purpura (HP:0000979) | 1.75935221 |
| 173 | Abnormality of serum amino acid levels (HP:0003112) | 1.73883607 |
| 174 | Neonatal death (HP:0003811) | 1.73777427 |
| 175 | Metaphyseal irregularity (HP:0003025) | 1.73712248 |
| 176 | Facial hemangioma (HP:0000329) | 1.73178940 |
| 177 | Abnormal urine phosphate concentration (HP:0012599) | 1.69455850 |
| 178 | Vacuolated lymphocytes (HP:0001922) | 1.67883778 |
| 179 | Delayed CNS myelination (HP:0002188) | 1.66813795 |
| 180 | Diastasis recti (HP:0001540) | 1.66745055 |
| 181 | Alacrima (HP:0000522) | 1.62389635 |
| 182 | Abnormal foot bone ossification (HP:0010675) | 1.61987368 |
| 183 | Megaloblastic anemia (HP:0001889) | 1.60533703 |
| 184 | Chronic hepatic failure (HP:0100626) | 1.60266397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 5.79321011 |
| 2 | MAP3K14 | 4.58864048 |
| 3 | EPHA2 | 3.57296190 |
| 4 | DYRK3 | 3.46583316 |
| 5 | IRAK4 | 3.07279054 |
| 6 | PBK | 3.04536776 |
| 7 | TXK | 2.93672763 |
| 8 | INSRR | 2.87671206 |
| 9 | CDK12 | 2.83558964 |
| 10 | MAP3K9 | 2.81761149 |
| 11 | WNK4 | 2.78449590 |
| 12 | BMPR2 | 2.71546941 |
| 13 | CASK | 2.69883493 |
| 14 | IRAK3 | 2.65699660 |
| 15 | SIK3 | 2.63807216 |
| 16 | MAP2K7 | 2.52177872 |
| 17 | ARAF | 2.35557246 |
| 18 | ICK | 2.26979545 |
| 19 | TYRO3 | 2.26822885 |
| 20 | EPHA3 | 2.26281142 |
| 21 | FGFR1 | 2.02210060 |
| 22 | AKT3 | 1.98094698 |
| 23 | ERBB3 | 1.96020258 |
| 24 | PINK1 | 1.81188062 |
| 25 | FGFR2 | 1.79530067 |
| 26 | DYRK1B | 1.76054515 |
| 27 | NEK6 | 1.69155571 |
| 28 | RIPK1 | 1.64826055 |
| 29 | PRPF4B | 1.64813189 |
| 30 | LATS1 | 1.62409397 |
| 31 | NEK9 | 1.61056990 |
| 32 | NME1 | 1.60560496 |
| 33 | TNIK | 1.58861239 |
| 34 | IKBKE | 1.57735861 |
| 35 | PDPK1 | 1.55073842 |
| 36 | MAP3K13 | 1.54556516 |
| 37 | ZAK | 1.54074444 |
| 38 | EIF2AK2 | 1.53358503 |
| 39 | PIK3CA | 1.52741378 |
| 40 | MET | 1.49654382 |
| 41 | STK38L | 1.48695140 |
| 42 | TEC | 1.43758590 |
| 43 | TNK2 | 1.41355876 |
| 44 | NLK | 1.39374604 |
| 45 | PKN1 | 1.39356618 |
| 46 | EIF2AK3 | 1.38312950 |
| 47 | CDK9 | 1.36793628 |
| 48 | CDK7 | 1.35926986 |
| 49 | TYK2 | 1.35162423 |
| 50 | PDGFRA | 1.33927110 |
| 51 | FRK | 1.27834288 |
| 52 | WNK1 | 1.26537940 |
| 53 | FGFR4 | 1.25930422 |
| 54 | PDK1 | 1.20204745 |
| 55 | JAK1 | 1.19448985 |
| 56 | BMPR1B | 1.19072407 |
| 57 | KSR2 | 1.16229618 |
| 58 | MAP3K6 | 1.14575592 |
| 59 | MST4 | 1.12607403 |
| 60 | STK39 | 1.11729895 |
| 61 | IKBKB | 1.10583046 |
| 62 | TTK | 1.10278200 |
| 63 | CHUK | 1.10136834 |
| 64 | MAPKAPK3 | 1.09142919 |
| 65 | BRAF | 1.07598236 |
| 66 | BMX | 1.07391469 |
| 67 | BLK | 1.06793514 |
| 68 | ADRBK2 | 1.01172213 |
| 69 | MARK3 | 0.99798447 |
| 70 | CDK3 | 0.98347011 |
| 71 | PRKCI | 0.97571558 |
| 72 | ACVR1B | 0.95941569 |
| 73 | SYK | 0.95436217 |
| 74 | MELK | 0.94311877 |
| 75 | JAK3 | 0.92409358 |
| 76 | EEF2K | 0.92288036 |
| 77 | TESK2 | 0.90052577 |
| 78 | MAP3K12 | 0.89225694 |
| 79 | CSNK1D | 0.86836294 |
| 80 | CSNK1E | 0.86775313 |
| 81 | PRKCE | 0.86620565 |
| 82 | DYRK1A | 0.86441887 |
| 83 | BCR | 0.85389768 |
| 84 | YES1 | 0.83976498 |
| 85 | EPHA4 | 0.83424111 |
| 86 | EPHB1 | 0.82998153 |
| 87 | MAP3K3 | 0.80197607 |
| 88 | LATS2 | 0.79746742 |
| 89 | PLK2 | 0.78700252 |
| 90 | CAMK1 | 0.76728388 |
| 91 | RET | 0.76572727 |
| 92 | NTRK3 | 0.76293776 |
| 93 | PRKACG | 0.73406454 |
| 94 | PRKCD | 0.72470275 |
| 95 | TAOK3 | 0.71967729 |
| 96 | SGK2 | 0.71652228 |
| 97 | SGK223 | 0.71158090 |
| 98 | SGK494 | 0.71158090 |
| 99 | IRAK1 | 0.71139253 |
| 100 | PIM2 | 0.71014664 |
| 101 | STK3 | 0.70440525 |
| 102 | EIF2AK1 | 0.69773996 |
| 103 | MAP3K2 | 0.66249651 |
| 104 | TBK1 | 0.64468170 |
| 105 | NTRK2 | 0.64252495 |
| 106 | PTK2 | 0.62774097 |
| 107 | BRSK1 | 0.61830205 |
| 108 | PRKCQ | 0.61543432 |
| 109 | AURKA | 0.61372091 |
| 110 | RAF1 | 0.60777972 |
| 111 | MAPK15 | 0.60687613 |
| 112 | BTK | 0.60661889 |
| 113 | GRK1 | 0.60481808 |
| 114 | PRKACB | 0.59228845 |
| 115 | MST1R | 0.58707818 |
| 116 | PRKCZ | 0.57965326 |
| 117 | MYLK | 0.57427495 |
| 118 | MKNK2 | 0.56593024 |
| 119 | ERBB2 | 0.55914310 |
| 120 | SIK2 | 0.55856321 |
| 121 | CAMK1D | 0.54867366 |
| 122 | ITK | 0.53512341 |
| 123 | MATK | 0.52420681 |
| 124 | PRKAA1 | 0.52021440 |
| 125 | CDC42BPA | 0.51814111 |
| 126 | MTOR | 0.51580978 |
| 127 | PRKG2 | 0.51097367 |
| 128 | MAP3K5 | 0.50690398 |
| 129 | PKN2 | 0.50520908 |
| 130 | JAK2 | 0.49875046 |
| 131 | CSNK2A2 | 0.48669932 |
| 132 | TRIB3 | 0.48429533 |
| 133 | SGK1 | 0.47880356 |
| 134 | FGR | 0.42843781 |
| 135 | PLK4 | 0.41523550 |
| 136 | RIPK4 | 0.41097041 |
| 137 | PIK3CG | 0.40444169 |
| 138 | FGFR3 | 0.38507053 |
| 139 | LYN | 0.38499840 |
| 140 | CSNK2A1 | 0.36772320 |
| 141 | IGF1R | 0.36579828 |
| 142 | HCK | 0.36516453 |
| 143 | ERBB4 | 0.36432050 |
| 144 | MAP2K6 | 0.36100683 |
| 145 | GRK6 | 0.35947890 |
| 146 | CAMK2G | 0.35480223 |
| 147 | PRKACA | 0.34338518 |
| 148 | CDK2 | 0.33740203 |
| 149 | NUAK1 | 0.33374484 |
| 150 | CDK8 | 0.32504894 |
| 151 | BRSK2 | 0.32497252 |
| 152 | PLK1 | 0.32315451 |
| 153 | NEK1 | 0.32265170 |
| 154 | CSNK1A1 | 0.31157646 |
| 155 | DYRK2 | 0.31024312 |
| 156 | BRD4 | 0.30776480 |
| 157 | ERN1 | 0.29316154 |
| 158 | DDR2 | 0.29083873 |
| 159 | STK24 | 0.28790353 |
| 160 | LMTK2 | 0.27604779 |
| 161 | PRKCA | 0.27488645 |
| 162 | MAP4K1 | 0.27144020 |
| 163 | TRPM7 | 0.26743308 |
| 164 | PRKCG | 0.25773837 |
| 165 | CSK | 0.25377560 |
| 166 | SGK3 | 0.24960482 |
| 167 | PRKAA2 | 0.24916847 |
| 168 | MAPK11 | 0.24765949 |
| 169 | RPS6KB1 | 0.23134829 |
| 170 | KIT | 0.22757342 |
| 171 | SCYL2 | 0.20814010 |
| 172 | PRKG1 | 0.20688939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Histidine metabolism_Homo sapiens_hsa00340 | 4.00973081 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.76756490 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.37125719 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.77906284 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.76523080 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.67150575 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.62023987 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46768413 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.41027757 |
| 10 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.39956932 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.10221211 |
| 12 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.08683359 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.03571758 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97067482 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.96966801 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.93074937 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89984977 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87177549 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84942135 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79585262 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78242951 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.76668536 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71594099 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68517632 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.68422880 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.64866620 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.64370309 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64333284 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63450023 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62320309 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.61978293 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55779044 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53070700 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52115228 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50039465 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 1.49999540 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48303746 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46773779 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44298696 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.43260893 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.43144250 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40532909 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35150359 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31841273 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31311101 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30247129 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29517337 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27294641 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27148631 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25101388 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17474871 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 1.16501023 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15596805 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13767614 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12405950 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12303526 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08829950 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07955947 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04478937 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04378033 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03429206 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02023938 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01408894 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01261471 |
| 65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00163498 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95238869 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.93781676 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89273226 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89234996 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87606351 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83635112 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82627753 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.82614236 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80742025 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78242017 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77325680 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.76877772 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76776912 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76402785 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73200596 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73196676 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70731771 |
| 83 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68677605 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67409880 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66711000 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66149557 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.65255345 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65062863 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64629468 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62354638 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59455729 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57214725 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.54904334 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54727049 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53879933 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53597626 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.51288824 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51283258 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51266441 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50495036 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50494519 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.50107601 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49127877 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47824896 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.46629040 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45843048 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45669901 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44531773 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43543911 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41879571 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41743712 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41524196 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41435145 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41117507 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38849470 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35885118 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32875903 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32855267 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.32299818 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31439027 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30140236 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30100119 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.30048717 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29335775 |
| 125 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28806728 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27687368 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.27626911 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27464514 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.27287407 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.24885516 |
| 131 | Taste transduction_Homo sapiens_hsa04742 | 0.24549250 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24478223 |
| 133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.24142801 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.23476060 |
| 135 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22555402 |
| 136 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22357011 |
| 137 | Basal transcription factors_Homo sapiens_hsa03022 | 0.12368706 |
| 138 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.10916652 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.10861684 |
| 140 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.07382518 |
| 141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.04882274 |
| 142 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04271753 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.0753010 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0495523 |
| 145 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0140264 |
| 146 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0056679 |

